117 related articles for article (PubMed ID: 9391668)
1. Immediate effects of middle ear pressure changes on the electrocochleographic recordings in patients with Menière's disease: a clinical placebo-controlled study.
Densert B; Densert O; Arlinger S; Sass K; Odkvist L
Am J Otol; 1997 Nov; 18(6):726-33. PubMed ID: 9391668
[TBL] [Abstract][Full Text] [Related]
2. Effects of middle ear pressure changes on clinical symptoms in patients with Ménière's disease--a clinical multicentre placebo-controlled study.
Odkvist LM; Arlinger S; Billermark E; Densert B; Lindholm S; Wallqvist J
Acta Otolaryngol Suppl; 2000; 543():99-101. PubMed ID: 10908991
[TBL] [Abstract][Full Text] [Related]
3. Electrocochleographic effects of ear canal pressure change in subjects with Menière's disease.
Storms RF; Ferraro JA; Thedinger BS
Am J Otol; 1996 Nov; 17(6):874-82. PubMed ID: 8915416
[TBL] [Abstract][Full Text] [Related]
4. Effect of static middle-ear and intracranial pressure changes on differential electrocochleographic response.
Franz B; Anderson C
Int Tinnitus J; 2008; 14(2):101-7. PubMed ID: 19205159
[TBL] [Abstract][Full Text] [Related]
5. The effects of transtympanic micropressure treatment in people with unilateral Meniere's disease.
Gates GA; Green JD; Tucci DL; Telian SA
Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):718-25. PubMed ID: 15210552
[TBL] [Abstract][Full Text] [Related]
6. [Local overpressure treatment reduces vestibular symptoms in patients with Menière's disease--secondary publication. A clinically randomised multicenter double-blind placebo-controlled study].
Thomsen JC; Sass K; Odkvist L; Arlinger S
Ugeskr Laeger; 2006 Jan; 168(4):378-80. PubMed ID: 16436239
[TBL] [Abstract][Full Text] [Related]
7. Summating potential and action potential ratio in Meniere's disease before and after treatment.
Orchik DJ; Shea JJ; Ge NN
Am J Otol; 1998 Jul; 19(4):478-82; discussion 483. PubMed ID: 9661758
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
[TBL] [Abstract][Full Text] [Related]
9. Electrocochleographic effects of ear canal pressure change.
Ferraro JA; Nunes RR; Arenberg IK
Am J Otol; 1989 Jan; 10(1):42-8. PubMed ID: 2719086
[TBL] [Abstract][Full Text] [Related]
10. Local pressure protocol, including Meniett, in the treatment of Ménière's disease: short-term results during the active stage.
Barbara M; Consagra C; Monini S; Nostro G; Harguindey A; Vestri A; Filipo R
Acta Otolaryngol; 2001 Dec; 121(8):939-44. PubMed ID: 11813899
[TBL] [Abstract][Full Text] [Related]
11. Positive pressure therapy for Ménière's disease or syndrome.
van Sonsbeek S; Pullens B; van Benthem PP
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD008419. PubMed ID: 25756795
[TBL] [Abstract][Full Text] [Related]
12. P-100 in the treatment of Ménière's disease: a clinical study.
Franz B; van der Laan F
Int Tinnitus J; 2005; 11(2):146-9. PubMed ID: 16639914
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial.
Silverstein H; Isaacson JE; Olds MJ; Rowan PT; Rosenberg S
Am J Otol; 1998 Mar; 19(2):196-201. PubMed ID: 9520056
[TBL] [Abstract][Full Text] [Related]
14. Electrocochleography and gentamicin therapy for Ménière's disease: a preliminary report.
Adamonis J; Stanton SG; Cashman MZ; Mattan K; Nedzelski JM; Chen JM
Am J Otol; 2000 Jul; 21(4):534-42. PubMed ID: 10912700
[TBL] [Abstract][Full Text] [Related]
15. Effect of transtympanic low-pressure therapy in patients with unilateral Menière's disease unresponsive to betahistine: a randomised, placebo-controlled, double-blinded, clinical trial.
Gürkov R; Filipe Mingas LB; Rader T; Louza J; Olzowy B; Krause E
J Laryngol Otol; 2012 Apr; 126(4):356-62. PubMed ID: 22365373
[TBL] [Abstract][Full Text] [Related]
16. Local overpressure treatment reduces vestibular symptoms in patients with Meniere's disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study.
Thomsen J; Sass K; Odkvist L; Arlinger S
Otol Neurotol; 2005 Jan; 26(1):68-73. PubMed ID: 15699722
[TBL] [Abstract][Full Text] [Related]
17. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
[TBL] [Abstract][Full Text] [Related]
18. Meniere's disease and middle ear pressure: vestibular function after transtympanic tube placement.
Park JJ; Chen YS; Westhofen M
Acta Otolaryngol; 2009 Dec; 129(12):1408-13. PubMed ID: 19922090
[TBL] [Abstract][Full Text] [Related]
19. Meniett clinical trial: long-term follow-up.
Gates GA; Verrall A; Green JD; Tucci DL; Telian SA
Arch Otolaryngol Head Neck Surg; 2006 Dec; 132(12):1311-6. PubMed ID: 17178941
[TBL] [Abstract][Full Text] [Related]
20. Intratympanic application of an antiviral agent for the treatment of Ménière's disease.
Guyot JP; Maire R; Delaspre O
ORL J Otorhinolaryngol Relat Spec; 2008; 70(1):21-6; discussion 26-7. PubMed ID: 18235202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
